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04 The Journal of Thoracic and Cardiobjective: Down syndrome is frequently associated with complete atrioventricular
eptal defect. The aim of this retrospective study was to evaluate the impact of
own syndrome on morphologic features, surgical management, and perioperative
nd long-term mortality in patients with complete atrioventricular septal defect.
ethods: Between October 1974 and March 2005, 476 patients with complete
trioventricular septal defect underwent surgery, 341 (71.6%) of whom had Down
yndrome. A total of 336 patients (70.6%) underwent primary repair, 95 patients
20%) underwent palliative surgery on an average of 3.4  2.9 years before repair,
nd 45 patients (9.4%) had no subsequent repair.
esults: Patients with Down syndrome (group D) exhibited higher preoperative
ulmonary artery pressure (P  .012) and resistance (P  .006) compared with
atients without Down syndrome (group ND). Rastelli types B and C were more
requent in group D (P  .002), but left atrioventricular valve anomalies were more
requent in group ND (P  .03). No difference was seen regarding operative
trategy (P  .117) and timing of repair (P  .32). Thirty-day mortality after
omplete atrioventricular septal defect repair was 4.9% in group D compared with
.6% in group ND. Actuarial survival after 20 years is 84%  2.5% (group D) and
5%  5.7% (group ND) (P  .252), and freedom from left atrioventricular
alve-related reoperation is 82%  2.9% (group D) and 72%  5.3% (group ND)
P  .004). Reinterventions on the left atrioventricular valve were required signif-
cantly more often in patients in group ND.
onclusions: The presence of Down syndrome in patients with complete atrioven-
ricular septal defect is not a risk factor for surgical repair. Because of the early
evelopment of pulmonary vascular disease, primary repair should be performed
ithin the first 6 months of life. In the long term, reintervention on the left
trioventricular valve is more often required in children with a normal chromosomal
attern.
omplete atrioventricular septal defect (CAVSD) is frequently (60%–86%)
associated with Down syndrome.1-7 Clinically relevant differences have
been identified in children with CAVSD with and without Down syn-
rome.8,9 Thus, left-sided obstructions and right ventricular dominance, as well as
eft atrioventricular valve (LAVV) abnormalities such as double orifice valve and
ingle papillary muscle, seem to be more prevalent in children with a normal
hromosomal pattern, whereas Rastelli types B and C are more often found in
atients with Down syndrome.8,9 Early progression of pulmonary vascular obstruc-
ive disease has been reported especially in patients with CAVSD associated with
own syndrome.10-12 Furthermore, children with Down syndrome may be at in-
reased risk for perioperative and long-term mortality,1,13 and have a predisposition
o more operative complications (eg, atelectasis and pulmonary edema) requiring a
vascular Surgery ● August 2007
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Donger duration of mechanical ventilation, intensive care,
nd hospital stay.14 Nevertheless, previous studies have
uggested an improved outcome for patients with Down
yndrome undergoing surgery for CAVSD.5,6 Thus, to clar-
fy these controversies, we analyzed the perioperative and
ong-term outcome in all children who underwent surgical
orrection for CAVSD in our center, with special emphasis
n the comparison of patients with and without Down
yndrome. This analysis may help to advise parents and
hysicians more precisely about the operative risk and long-
erm morbidity of this cardiac defect.
aterials and Methods
ata from 476 patients with CAVSD who underwent operation
etween October 1974 and March 2005 at the German Heart
enter, Munich, were analyzed. Patients with major associated
ardiovascular anomalies (tetralogy of Fallot, double-outlet right
entricle, transposition of the great arteries, and total anomalous
ulmonary venous drainage) and patients with intermediate type of
trioventricular septal defect were not included in the analysis. Of the
76 children, 341 (71.6%) presented with Down syndrome (group D)
nd 135 presented with a normal chromosomal pattern (group
D). Overall, 303 patients (64%) (group ND n  88 [65%], group
n  215 [63%]) exhibited additional minor cardiac anomalies
Table 1). Twenty-six patients (5.5%) had right (n  21) or left
n  5) ventricular dominance. Extracardiac anomalies were ob-
erved in 39 patients, including duodenal atresia/stenosis, Hirsch-
prung’s disease, congenital tracheal stenosis, Apert syndrome,
nd CHARGE association. A total of 336 patients (71%) had
Abbreviations and Acronyms
CAVSD complete atrioventricular septal defect
LAVV  left atrioventricular valve
ABLE 1. Incidence of minor cardiovascular anomalies in
All patients
No.
%atients (n) 476
SD II/PFO 180 37.8
DA 135 28.4
PSVC 29 6.1
ommon atrium 12 2.5
zygos extension of IVC 10 2.1
nomalous right subclavian artery 10 2.1
dditional VSDs 14 2.9
ubaortic stenosis 7 1.5
extrocardia 2 0.4
ongenital heart block 2 0.4
APVC 2 0.4
genesia of IVC 1 0.2
SD, Atrial septal defect; IVC, inferior vena cava; LPSVC, left persistent sup
atent ductus arteriosus; PFO, patent foramen ovale; VSD, ventricular septal de
The Journal of Thoracicrimary repair, 89 patients (66%) in group D and 247 patients
72%) in group ND. Age at primary repair ranged between 1
onth and 10.3 years (mean 0.9  1.3 years, median: 0.53 years).
total of 152 patients (45.2%) were younger than 6 months.
eight varied between 1.3 and 23.2 kg (median: 5.3 kg). A total
f 36 patients underwent primary repair weighing less than 4000 g.
ean age at primary repair was 0.8  1.0 years in group D and
.3  1.8 years in group ND. A total of 95 patients (20%)
nderwent palliative surgery 5 days to 17.8 years (mean: 3.4 2.9
ears median: 2.8 years) before repair. In a group of 45 patients
9.4%), palliative surgery remained the only option. In the patient
roup with previous pulmonary artery banding, age at repair
anged from 1.4 months to 18 years (mean: 3.7  3.2 years,
edian: 3.1 years), and weight ranged from 2.8 to 46.2 kg (me-
ian: 12 kg).
According to the intraoperatively assessed Rastelli classifica-
ion,15 64% of the patients who underwent corrective surgery
resented with type A, 3% presented with type B, and 33%
resented with type C. Eighteen of 431 patients (4.2%) who
nderwent CAVSD repair presented with LAVV anomalies (dou-
le orifice mitral valve [n  4], single left ventricular papillary
uscle [n 8], dysplastic valve with extreme deficiency of LAVV
issue [n  6]). A total of 311 patients underwent cardiac cathe-
erization before repair, which included hemodynamic evaluation
f systemic and pulmonary blood flow and resistance (Table 2).
atheterization was performed in 95% of the patients who under-
ent operation between 1974 and 1994 and in 37% of the patients
ho underwent operation in the last decade.
perative Technique
n 172 patients (40%) of the early study period, repair was per-
ormed using hypothermic circulatory arrest (mean circulatory
rrest time 60 8 minutes). Continuous extracorporeal circulation
nd moderate hypothermia (rectal temperature 24°C-28°C) were
sed in the remaining patients and is the currently used technique.
ean cardiopulmonary bypass time at primary repair was 114 
6 minutes, and mean aortic crossclamp time was 80  21 min-
patients with complete atrioventricular septal defect
Group D Group ND
No.
%
No.
%
P value
341 135 .62
137 40.2 43 31.8 .678
112 32.8 23 17.0 .001
15 4.4 14 10.4 .013
2 0.6 10 7.4 .001
0 0 10 7.4 .001
6 1.8 4 3.0 .402
8 2.3 6 4.4 .216
3 0.9 4 3.0 .089
0 0 2 1.5 .024
0 0 2 1.5 .024
1 0.3 1 0.7 .496
0 0 1 0.7 .112
vena cava; PAPVC, partial anomalous pulmonary venous connection; PDA,476
erior
fect.
and Cardiovascular Surgery ● Volume 134, Number 2 305
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Dtes. In 32 cases (7.4%) (mainly in the early study period: 1974-
978) repair was performed using the 1-patch technique described
y Rastelli and colleagues.16 Since 1978, the 2-patch technique has
een applied.17 The ventricular septal defect was closed with a
ontinuous 4.0 to 6.0 Prolene suture to affix a semicircular Dacron
atch keeping the suture line on the right side of the crest of the
entricular septum. The valve leaflets were fixed on the upper edge
f the patch with interrupted sutures, starting at the central meeting
oint of the anterior and posterior leaflets. Any attempt was made
o close the anterior commissure or “cleft” of the LAVV as
ompletely as possible. In 12 patients, the “cleft” had to be left
pen to prevent LAVV stenosis. In general, the LAVV diameter
as assessed intraoperatively with a Hegar dilator and compared
ith the nomograms of Rowlatt and coworkers.18 A separate
acron patch was then sutured to the superior aspect of the
entricular patch to close the atrial defect. In cases of sparse tissue
n front of the coronary sinus, the suture line was passed superior
o the atrioventricular node, placing the coronary sinus to the left
ide (n  26 patients); otherwise the atrial patch was anchored
ith superficial stitches along the valve ring, avoiding the conduc-
ion system. Additional surgical procedures at repair included
losure of patent ductus arteriosus in 84 patients, debanding in 94
atients (followed by patch enlargement of the pulmonary artery in
6 patients and pulmonary artery resection with end-to-end anas-
omosis in 2 patients), ligation of left superior caval vein in 7
atients, resection of subaortic stenosis in 7 patients, and closure of
dditional muscular ventricular septal defects in 5 patients.
Pulmonary artery banding was performed in cases with high
ulmonary vascular resistance (6 U/m2) not reactive to oxygen
ith substantial left-to-right shunt, hypoplastic left ventricle (left
entricular end-diastolic volume  50% of predicted normal), or
oexisting coarctation.
ollow-up
perative survivors are regularly followed up at 3-, 6-, or 12-
onth intervals at the outpatient department of the Department of
ediatric Cardiology at the German Heart Center, Munich, includ-
ng physical examination, electrocardiography, radiography, and
chocardiography. Follow-up data were obtained from medical
ecords of follow-up visits and additional telephone interviews
ABLE 2. Cardiac catheterization data before primary repa
All patients
mean  SD
atients (n) 336
AP (mean) (mm Hg) 5.8 2.4
AP (mean) (mm Hg) 6.5 2.7
V (systolic) (mm Hg) 73.0 13.2
AP (systolic) (mm Hg) 68.8 15.1
oom air Qp/Qs 3.3 2.1
oom air Rp/Rs 0.35 0.3
oom air PVRI (U/m2) 4.4  3.0
eft-to-right shunt 65.6 16.5
AP, Right atrial pressure; LAP, left atrial pressure; RV, right ventricle; PA
ulmonary-to-systemic resistance ratio; PVRI, pulmonary vascular resistaith the family physicians. a
06 The Journal of Thoracic and Cardiovascular Surgery ● AuguAs of December 2005, 368 of 431 patients who underwent
AVSD repair are alive. The follow-up is 95% complete. Twenty-
our patients were lost to follow-up. The follow-up extends up to
0 years (mean 6.9  7.2 years, with a cumulative total of 3262
atient-years); 88% of the survivors are in New York Heart As-
ociation class I, 87% are in sinus rhythm, and 83% are without
ardiac medication.
tatistical Analysis
aplan–Meier analysis was used to study patient and event-free
urvival status. The log–rank test was used to ascertain differences
etween groups. The chi-square test (for categoric data) and Mann–
hitney test (for measured data) were used to determine statistical
ignificance. Univariate analyses were used to assess whether there
as a relationship between outcome (30-day mortality) and pos-
ible predictors. Significant factors were entered into a multivariate
roportional hazard model (multiple logistic regression) to assess
he independent impact of potential risk factors. All data were
nalyzed with the Statistical Package for the Social Sciences
oftware, release 11.5 (SPSS, Chicago, Ill).
esults
reoperative Patient Data
ifty-six percent of the patients in group D and 61.5% in
roup ND were female (P  .276). Patients in group D
howed a significantly higher rate of Rastelli types B (4% vs
%) and type C (37% vs 23%) compared with those in
roup ND (P  .002). Sex and the common atrioventricular
alve morphology (Rastelli type) did not affect survival
Table 3). There was no difference in the overall incidence
f minor associated cardiac anomalies (P  .62) or the
ncidence of extracardiac anomalies (P  .11).
However, in a subgroup analysis we found a significant
ifference in the incidence of minor cardiac anomalies, such
s patent ductus arteriosus, left persistent superior vena
ava, common atrium, azygos extension of inferior vena
ava, and dextrocardia (Table 1). The incidence of LAVV
patients with and without Down syndrome
Group D Group ND
P value
mean  SD mean  SD
247 89
5.8 2.4 6.0 2.5 .494
6.6 2.7 6.4 2.8 .762
73.4 11.7 71.1 16.2 .516
70.5 12.4 64.9 19.6 .012
3.2 2.2 3.4 1.8 .539
0.39 0.3 0.25 0.2 .004
4.8 3.0 3.5 2.9 .006
64.4 16.6 68.6 15.9 .105
lmonary artery pressure; Qp/Qs, pulmonary-to-systemic flow ratio; Rp/Rs,
dex; SD, standard deviation.ir in
P, punomalies (double orifice mitral valve, single papillary mus-
st 2007
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Dle, dysplastic valve) was significantly lower among pa-
ients in group D compared with group ND (P  .03).
Analysis of the preoperative hemodynamic variables of
oth patient groups (Table 2) revealed that patients in group
exhibited significantly higher pulmonary vascular resis-
ance (mean: 4.8  3.0 [group D] vs 3.5  2.9 [group ND],
 .006) and pulmonary-to-systemic resistance ratios
mean: 0.39  0.3 [group D] vs 0.25  0.2 [group ND],
 .004) compared with patients in group ND. The same
ifference in these pulmonary vascular parameters was
ound for the subgroups of patients aged less than 6 months
t primary repair. No significant difference was found in
egard to the surgical strategy (P  .117) and timing of
epair (6 vs 6 months) (P  .32). Seventy-two percent
f the patients in group D and 66% of the patients in group
D underwent primary repair; cardiopulmonary bypass
imes were equal for both groups (median: 107 minutes
group D] vs 110 minutes [group ND] (P  .91). Patients
pent an average of 8.5  8.6 days in the intensive care unit
ith no significant difference between both groups (group D
8.1  7.6 days], group ND [9.7  10.7 days], P  .789).
owever, patients of group D required a longer mechanical
entilation time (median: 3 days) than patients in group ND
median 2 days) (P  .012).
Overall 30-day mortality for all patients who underwent
AVSD repair was 5.1% (22/431). Of the 336 patients who
nderwent primary correction, 18 (5.4%) died early. De-
pite a trend toward primary repair in young infants (6
onths), 30-day mortality could be reduced from 8.6% in
he period from 1974 to 1989 to 3.4% in the period from
990 to 2004. Thirty-day mortality after primary repair
howed no significant difference between both patient
roups (group D 5.3%, group ND 5.6%, P  .534). There
as also no difference in 30-day mortality when the sub-
ABLE 3. Analysis of potential risk factors associated
trioventricular septal defect repair
actor Univariate P value
emale sex .076
own syndrome .677
astelli type .016
p/Rs  0.4 .414
inor cardiovascular anomalies .590
nbalanced ventricle .921
oexisting CoA .549
AVV anomalies .002
ge at repair (6 mo) .110
perative technique: (1-patch technique) .027
ate of operation (1990) .040
revious PAB .613
V, Atrioventricular; CoA, coarctation of the aorta; Rp/Rs, pulmonary-to-s
ricular valve.roups of patients with age at primary repair less than 6 C
The Journal of Thoraciconths and more than 6 months were analyzed. Of the 95
atients who had prior palliative surgery, 6 (6%) died within
0 days postoperatively. Multiple logistic regression analy-
is revealed young age at repair (6 months), earlier date of
peration (1990), and associated LAVV anomalies as
ignificant risk factors for 30-day mortality (Table 3). Age
ess than 6 months, however, was a risk factor only in the
arly study period. Overall, 40 children (9.3%) died late
fter repair, 25 (8.1%) in group D and 15 (12.1%) in group
igure 1. Actuarial survival after CAVSD repair. Kaplan–Meier
stimate of survival for patients with and without Down syn-
rome. The actuarial survival at 20 years is 84%  2.5% for
atients with Down syndrome and 75%  5.7% for those without.
30-day mortality in patients who underwent complete
Multivariate P value Odds ratio Confidence interval (95%)
.007 6.08 1.62-22.8
.004 4.54 1.61-12.8
.004 4.79 1.65-13.9
ic resistance ratio; PAB, pulmonary artery banding; LAVV, left atrioven-with
ystemAVSD, Complete atrioventricular septal defect.
and Cardiovascular Surgery ● Volume 134, Number 2 307
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DD. Late deaths were mainly due to progressive cardiac
ailure and late pulmonary infections. Actuarial survival 20
ears after CAVSD repair was 84%  2.5% in group D and
5%  5.7% in group ND (P  .252) (Figure 1).
igure 2. Freedom from reoperation after CAVSD repair. Kaplan–
eier estimate of freedom from reoperation for patients with and
ithout Down syndrome. Freedom from reoperation at 20 years is
5% 3.7% for patients with Down syndrome and 71% 5.3% for
hose without. CAVSD, Complete atrioventricular septal defect.
igure 3. Freedom from LAVV-related reoperation after CAVSD
epair. Kaplan–Meier estimate of freedom from LAVV-related re-
peration for patients with and without Down syndrome. Freedom
rom reoperation at 20 years is 82%  2.9% for patients with
own syndrome and 72%  5.3% for those without. LAVV, Left
trioventricular valve; CAVSD, Complete atrioventricular septal
efect. a
08 The Journal of Thoracic and Cardiovascular Surgery ● Auguncidence of Reoperation
eoperation was defined as a second operation after
AVSD repair requiring cardiopulmonary bypass. Within
n observation period of more than 30 years, 44 patients
11.1%) in group D and 29 patients (22.7%) in group ND
equired a reoperation 7 days to 8.0 years (mean 1.2  2.0
ears) after primary repair. Thus, freedom from reoperation
t 20 years in group D was 75%  3.7% compared with
1%  5.3% in group ND (Figure 2); the difference was
ot significant (P  .094). In contrast, freedom from
eoperation on the LAVV at 20 years was 82%  2.9%
group D) compared with 72%  5.3% (group ND) (P 
004) (Figure 3). Approximately half of the patients (48%)
nderwent reoperation within 3 months after repair.
The main indication (82%) for reoperation was signifi-
ant LAVV incompetence. Repair of LAVV was possible in
ost cases, except in 27 patients who required valve re-
lacement. Both patient groups showed no significant dif-
erence in the need for valve replacement (P  .071). Other
ndications for reoperation were subaortic stenosis, recur-
ent ventricular septal defect, and tricuspid valve incompe-
ence. The number and type of reoperation are summarized
n Table 4. Overall, 24 patients, 8 (6.3%) in group ND and
6 (5.1%) in group D, required a permanent pacemaker,
ainly for postoperative complete atrioventricular block.
here was no difference in the incidence of postoperative
omplete atrioventricular block between both patient groups
P  .856).
iscussion
he majority of patients who are referred for repair of
AVSD exhibit Down syndrome. Controversy exists in the
iterature as to how the presence of Down syndrome may
ABLE 4. Incidence and type of reoperation after complete
trioventricular septal defect repair
AVV repair 21
AVV replacement 13
AVV repair  VSD closure 9
AVV repair  resection of subaortic stenosis 6
AVV repair  RAVV repair 4
AVV repair  RAVV repair  VSD closure 4
SD closure 4
esection of subaortic stenosis 3
AVV repair  VSD closure 2
ther 7
otal 73
AVV, Left atrioventricular valve; RAVV, right atrioventricular valve; VSD,
entricular septal defect. Other reoperations  coarctation of the aorta
esection (1), tricuspid valve repair (1), mitral valve replacement  VSD
losure (1), mitral valve replacement  resection of subaortic stenosis (1),
itral valve repair atrial septal defect VSD closure (1), tricuspid valve
epair  atrial septal defect closure (1), resection of subaortic stenosis 
ortic valve repair (1).
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Dnfluence the perioperative results and the long-term out-
ome of these patients.
ulmonary Predisposition in Down Syndrome
AVSD in patients with Down syndrome has been reported
o be associated with an unusually high incidence of pul-
onary hypertension and pulmonary vascular obstructive
isease.10,11 On the basis of histologic specimens from
atients with and without Down syndrome, Yamaki and
ssociates11 reported a more severe form of pulmonary
ascular disease in patients with Down syndrome, with
ignificant differences in the amount of intimal lesions and
edial thickness of the small pulmonary arteries. On the
asis of these findings, early repair within the first 6 months
f life was recommended. Rizzoli and coworkers19 found a
ignificantly higher pulmonary vascular resistance (4.5
/m2 vs 1.93 U/m2) in patients with Down syndrome com-
ared with patients without. As other studies have,12,20 we
lso found a significant difference in pulmonary vascular
esistance (mean: 4.8 vs 3.5 U/m2) and pulmonary-to-
ystemic resistance ratio (0.39 vs 0.25) in patients with and
ithout Down syndrome, regardless of the age at primary
epair. Children with Down syndrome may also have a
redisposition to more perioperative complications, includ-
ng pulmonary atelectasis and pulmonary edema, requiring
longer duration of mechanical ventilation, intensive care
tay, and hospitalization.14,19 Although we found the dura-
ion of mechanical ventilation to be longer in patients of
roup D, the total time spent in the intensive care unit was
ot different. Thus, the less favorable pulmonary predispo-
ition in Down syndrome had no influence on the need for
arly postoperative care.
eft-sided Valve Morphology
ifferences also exist regarding the LAVV morphology and
he presence of left ventricular obstructive lesions.8,9 Alexi-
eskishvili and associates3 found an incidence of more
omplicated LAVV anomalies in 10.6% of patients with
own syndrome compared with 17.6% in those without.
his difference did not reach significance. In our series,
hildren with a normal chromosomal pattern presented with
significantly higher incidence of LAVV anomalies (dou-
le orifice mitral valve, single papillary muscle, dysplastic
alve). These anomalies have been identified as indepen-
ent risk factors for 30-day mortality.3,5 Marino9 stated that
astelli type C is more prevalent in patients with Down
yndrome, a finding that could be confirmed in our study,
ecause patients with Down syndrome showed a signifi-
antly higher rate of Rastelli types B (4% vs 1%) and type
(36% vs 23%) compared with patients without Down
yndrome. However, in our study the Rastelli type had no
nfluence on outcome after CAVSD repair. We also found
o significant difference in the incidence of minor associ- i
The Journal of Thoracicted cardiac anomalies in patients with or without Down
yndrome, similar to other studies.19
urvival
espite the above-mentioned differences in patients with
AVSD with and without Down syndrome, we could not
dentify the presence of Down syndrome to be an indepen-
ent incremental risk factor. Thirty-day mortality (5.3% vs
.6%) and 20-year survivals (84% 2.5% vs 75% 5.7%)
ere not found to be different. In contrast with Formigari
nd coworkers,6 who reported a higher prevalence of pul-
onary artery banding procedures in children with normal
hromosomal pattern, we found no significant difference
etween both patient groups regarding the operative strat-
gy (primary repair vs 2-stage repair) (P  .117) and the
ge at repair (6 months vs  6 months) (P  .32).
urthermore, our results compare favorably with other stud-
es,2,3,5,6,19 because no differences in 30-day mortality and
ong-term survival were detected. Thirty-day mortality was
.7% and 16% in children with Down syndrome and 11.1%
nd 12% in children without Down syndrome in the studies
y Alexi-Meskishvili and coworkers3, and Al-Hay and as-
ociates,5 respectively. The difference was not significant in
ither investigation. These data, however, are in contrast
ith those of Morris and colleagues,1 who reported on 59
hildren with a 2-year survival after repair of 77%  6% in
atients with Down syndrome compared with 100% in
hildren without Down syndrome. All deaths in their series
10/59) occurred in children with Down syndrome and were
ardiac related. In 1985, Bull and colleagues21 questioned
he advisability of repairing CAVSD in patients with Down
yndrome, on the assumption that early surgery carries a
igh risk for an uncertain prospect. Bull and coworkers
eported a survival of 80% at 15 years in 67 patients with
edical management and recommended medical treatment,
nless a unit can offer exceptional surgical results. Cur-
ently, primary repair of CAVSD is safe and can be accom-
lished with an operative mortality less than 4% even in
oung infants, thus offering excellent short- and long-term
esults.2,22
eoperation
n our series, 11.1% of the patients in group D and 22.7% in
roup ND required reoperation. Overall freedom from re-
peration at 20 years in children with Down syndrome was
5%  3.7%, compared with 71%  5.3% in children with
ormal chromosomes; the difference was not significant (P
.094). However, patients in group ND required signifi-
antly more reoperations on the LAVV, presumably be-
ause LAVV anomalies (double orifice mitral valve, single
apillary muscle) were more prevalent in patients without
own syndrome, as has been described by others.5 Anncreased risk for reoperation in children without Down
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3
CH
Dyndrome has been described by various investigators.5,6,23
ormigari and associates6 reported a higher prevalence of
ecurrent subaortic stenosis in children with normal chro-
osomes, and in their study reintervention on the LAVV
as also more frequent in patients without Down syndrome.
onclusions
ecause of a tremendous evolution in pediatric cardiac
urgery, primary repair of CAVSD is safe today and can be
ccomplished with an operative mortality less than 4% even
n young infants, thus offering excellent short- and long-
erm results. In our experience the presence of Down syn-
rome in patients with CAVSD does not affect operative
trategy, timing of repair, or postoperative outcome and is
hus not considered an additional risk factor. Physicians and
arents should be aware that, in the long term, reinterven-
ion on the LAVV may be required more often in children
ith a normal chromosomal pattern.
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